Organigram Global Inc. (OGI) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

good morning my name is ed and i'll be your conference operator today at this time i would like to welcome everyone to the organogram global second quarter fiscal 2026 earnings conference call after the speaker's prepared remarks there'll be a question and answer session please limit yourself to one question and one follow-up you may re-queue for additional questions thank you i'll now turn the call over to max schwartz director of investor relations Thank you very much, and good morning, everyone. Thank you so much for joining us today. As a reminder, this call is being recorded, and a replay will be available on our website within 24 hours. Today's call will include forward-looking statements. Actual results could differ material due to a number of risk factors outlined in our filings and cautionary statements included in our Q2 fiscal 2026 press release and MD&A. We'll also reference certain non-IFRS measures, such as adjusted EBITDA, adjusted gross margin, and free cash flow. definitions and reconciliations are available in our disclosure materials. Unless otherwise noted, market share data is sourced from High Fire, Weed Crawler, potential boards, retailers, and our own internal sales tracking. Discussing our results today are James Yamanaka and Greg Guyatt, CEO and CFO of Organigram Global, respectively. Once again, I welcome you to today's call. And with that, I will turn the call over to James. Thank you, Max, and good morning, everyone. Thank you for joining us today. It's now been about four months since I joined Organigram, and after an initial period of deep operational review across the business, my focus remains on execution, leveraging our strengths, addressing areas for improvement, and fully realizing the financial and strategic contributions of Sani...